Multiple Sclerosis Society of Canada

National News Releases

Showing 11-20 of 22 national news releases.

Canadian Prospective Cohort Study to Understand Progression in Multiple Sclerosis Awarded Nearly $1.35 Million to Investigate the Impact of Pediatric-Onset MS Into Adulthood

  • National News Release

Study will provide greater insights into multiple sclerosis disease progression from childhood through adulthood TORONTO, O.N. (April 6, 2022) – The Multiple Sclerosis (MS) Society of Canada announced today a nearly $1.35 million investment from Biogen Canada Inc., Hoffmann-La Roche Limited (Roche Canada), Read the full article

New Research Study Investigates Earliest Predictors of MS Across Diverse Groups to Identify People At-Risk of Worse Disability Outcomes

  • National News Release

MS Society of Canada partners with National MS Society to support a Canadian-led study investigating the MS prodrome The Multiple Sclerosis Society of Canada (MS Society) is proud to announce a partnership with the National Multiple Sclerosis Society (NMSS) to support a study that aims to understand... Read the full article

A&W Canada Partners with Christine Sinclair for the 13th Annual Burgers to Beat MS Campaign to Help Take on Multiple Sclerosis

  • Announcement,National News Release

A&W Canada announces Burgers to Beat MS Day, where $2 from every A&W Teen Burger ® sold across Canada on Thursday, August 19 th will be donated to the MS Society of Canada to support people living with MS VANCOUVER, BC, July 28, 2021 – A&W Canada and the MS Society of Canada are teaming up with Christine... Read the full article

COVID-19 Vaccine Guidance for People Living with MS

  • Announcement

Last updated – July 13, 2022 For recommendations on COVID-19 vaccines, please refer to National Advisory Committee on Immunization (NACI). People living with multiple sclerosis (MS) are seeking peace of mind on the safety and effectiveness of the COVID-19 vaccines. In response, MS Society partner organizations... Read the full article

New Research Study Investigates Metformin as a Therapy to Promote Brain Repair and Reduce Disability in Children and Young Adults with MS

  • National News Release

MS Society of Canada invests $400,000 in Canadian Team of MS Researchers Toronto, ON – February 2, 2020 – Today the Multiple Sclerosis Society of Canada announced $400,000 in funding to support a pilot clinical trial to investigate the use of metformin as a therapy for children and young adults with... Read the full article

Open navigation